PB Fintech stock hits new low, down 48% since insurance rule plan

How can profit rise 42.5% yet the stock crash 48%?

The 42.5% profit rise is the company's past performance; the 48% stock crash is investors pricing its future. Since September 23, when regulator IRDAI, India's insurance watchdog, proposed capping insurance commissions, Policybazaar's entire revenue, commissions from policies it sells, is threatened. CEO Yashish Dahiya, the company's co-founder, admitted revenue could fall 30% if commissions drop 60%. Investors pay for what's next, not what happened.

Can Policybazaar just start making its own insurance?

It could try. Dahiya says the company may seek an insurance manufacturing licence, a permit to create and sell its own policies, if commission caps make distribution unprofitable. Their health book runs at a 93% combined operating ratio, and reinsuring half could yield 60% return on equity. But manufacturing means taking underwriting risk and huge capital, a different business from broking. Our read: it's a threat to regulators, not a near-term move.

How is it even 48% off if analysts can't agree on the damage?

The spread reflects just how wide the possible outcomes are. Bernstein, the most bullish of the three, sees the caps cutting insurance take rates by 40%, FY28 revenue by 36% and profit by 34%, yet still keeps an 'Outperform' rating and a target of ₹1,085. Dolat and HSBC are more cautious, cutting EPS estimates by 2-4% and flagging higher operating costs and the threat to the PoSP model. So the 48% fall prices in the worst case, while the retained buy ratings bet on the final rules being softer, cost cuts and growth from Paisabazaar and other lines cushioning the blow.

If commissions are capped, who actually pays for the difference?

The commission cut lands on distributors like Policybazaar, but the paper's aim is that insurers pass savings to customers through lower premiums, which could drive 15–20% volume growth that partially offsets revenue loss. Insurers face tighter expense caps too, so they must cut distribution costs. Policybazaar is exploring charging for claims support it now gives free. Our read: the customer eventually pays less in premium, not more, as the regulator's design intends.

Why do some brokerages still rate the stock a buy after such a big profit cut?

Bernstein keeps an Outperform rating even while estimating a 34% hit to FY28 profit because it sees the damage as one-time and cushioned. It counts on three offsets: cost rationalisation in call-centre and marketing spend, growth from Paisabazaar's credit business, and lower pricing driving enough extra volume to claw back some lost revenue. The other brokerages see those offsets as too weak, which is why they hold or reduce. Our read: the bull case is a bet that IRDAI softens the final caps, not that the business escapes untouched.

Can Policybazaar charge for services it now gives free?

It is exploring exactly that. Management said the proposed rules could open up opportunities to charge for claims support that Policybazaar now provides free, and for services like managing garage networks and hospital networks. But these are being discussed informally with the regulator, and the company says it will only announce specifics after obtaining regulatory approval and seeing the final rules. So charging for claims help is a possible new revenue line, not a locked plan yet.

Why would Policybazaar's own customers lose out if it starts charging for claims help?

The proposed rules force Policybazaar to find revenue beyond commissions, and claims support is one service it now gives free that it could charge for. But the same rules cap what insurers can spend overall, so any new fee on customers would sit on top of their premium, not replace it. The regulator's own case is that lower distribution costs should cut premiums, which is why it wants 15-20% higher volumes to cushion the blow. Our read: charging for claims help would blunt the regulator's affordability argument, so it faces an uphill path.

Is there anything stopping the regulator from just imposing the caps as proposed?

The consultation process is the main check. Over 650 stakeholders responded, and IRDAI extended the feedback deadline from October 25 to October 31, signalling it is weighing objections from agents, brokers and insurers. The paper itself says the framework is an evolving exercise, with a review planned alongside product reforms during FY28. Our read: the caps land, but the final shape will be phased and adjusted, not a single, definitive intervention.

How likely is IRDAI to soften these caps?

Feedback ran past 650 comments, and IRDAI extended the deadline by six days to October 31, signaling it is listening. Still, the regulator's own data shows commissions rising 125% while premiums grew less, so the direction is set. The final rules could phase in cuts or raise caps on some products. Watch the October 31 feedback and final draft for the real shape.

What did IRDAI propose on September 23?

On September 23, 2026, India's insurance regulator IRDAI released a consultation paper titled 'Recalibrating Economics of Insurance Distribution.' It proposes capping commissions insurers pay to sellers like Policybazaar, with zero commission on mandatory third-party motor insurance and health first-year commissions cut from about 30% to 15%. The market treated the proposal as near-final, triggering a sharp sell-off.

What is the company doing to make up for the lost commissions?

Management is planning to restructure its PoSP distribution business if the rules pass as proposed, and is in informal talks with the regulator about other options. It is exploring charging for services it now gives free, like claims support and hospital networks, and has said lower commissions could let insurers cut prices, driving 15-20% higher volumes to partly offset losses. Our read: the company is betting on volume growth and new fees, not waiting for the rules to be softened.

Who else gets hurt if Policybazaar's commissions shrink?

The pain is not just PB Fintech's. Banks and NBFCs that earn fee income selling loan-linked insurance face declining payouts, since the rules cap commissions on credit-life products at 2% to 2.5%. Even insurers suffer indirectly: tighter expense limits push them to cut distribution costs, and if bank partners sell less at lower payouts, their premium growth suffers. The regulator's own data shows commissions rose 125% while premiums lagged, which is precisely why the cuts are aimed at the whole chain. Our read: every seller of insurance is being squeezed, not just online platforms.

Why is the stock still falling when profit is up 42%?

PB Fintech's profit grew 42.5% year on year to ₹192.4 crore in Q2 FY27, and revenue rose 35%, so the quarterly numbers look strong. But analysts are looking past the quarter to what the proposed commission caps would do to future earnings. HSBC cut its EPS estimates by 2-4%, and Dolat Capital cut its target price to ₹1,090, citing higher advertising costs and the uncertainty around the insurance rules. The stock now trades at about half its September market cap because the market is pricing in a future where PB Fintech earns far less per policy sold, not one where it just reported a good quarter.

Why would the company pay more for ads just as its main income is about to shrink?

Dolat Capital's numbers make that contradiction visible: Q2 revenue beat was 4.2% below its estimate, and EBIT missed by 32.7%, mainly because advertising and other expenses rose. The company's core online business, which includes Policybazaar, grew revenue 39.5%, so it is spending to defend share in a market where rivals face the same commission shock. Our read: the ad spend is a bet that whoever holds customers when the rules land will keep them, and the cost is acceptable because the alternative is losing the base that future fee income depends on.

Why are analysts still split on the stock after the sell-off?

Three brokerages read the same numbers differently. HSBC and Dolat Capital cut their EPS estimates and kept cautious ratings, citing higher ad costs and uncertainty over the proposed rules. Bernstein kept its 'Outperform' call and a target of ₹1,085, pointing to 38% growth in consolidated premiums and 22% growth in core credit disbursements. The split comes down to what each weights: near-term regulatory pain versus the company's ability to grow premiums and credit around it. Our read: Bernstein is betting the volume growth and cost cuts outrun the commission hit, while the others are not.

Why would commission caps hurt Policybazaar so badly?

Policybazaar is a broker: it does not make insurance, it sells policies made by other companies and earns a commission on each sale. In the April–June 2026 quarter, it kept ₹18.50 of every ₹100 of premium. The regulator's September proposal would cut that commission sharply, to zero on mandatory motor third-party cover and to 15% on first-year health sales, from the prevailing 30%. That is a direct cut to its core income.

Why would the stock keep falling even as profit rises?

Profit and revenue grew last quarter, but the stock fell because investors are pricing in the future, not the past. The regulator's proposal could cut commissions by up to 60% on general insurance, which Bernstein estimates could slash FY28 revenue by 36% and profit by 34%. Brokerages have cut earnings estimates, citing regulatory uncertainty and higher costs. The profit reported is before those rules take effect, so the market sees it as a lagging indicator. Our read: the market is treating the current quarter as the last clean one, not a sign of what comes next.

Can Policybazaar just cut costs to offset the loss?

Partially. Contact centre costs alone account for nearly 20% of revenue, and growth-linked expenses like call-centre hiring, variable payouts and performance marketing could be pulled back in FY28, per Bernstein. The company also plans to slow hiring, having taken on about 6,000 people in the first half, when it might have hired nearer 2,000 had the draft been out earlier. But cutting costs only softens the blow; Bernstein still models FY28 profit falling below FY27 before recovering. Our read: cost cuts buy time, not a solution, since the core commission line itself is capped.

If costs and commissions are both capped, does the company have other levers to pull?

PB Fintech's CEO has said the company is in informal talks with the regulator about options it will announce only after approval, including charging for claims support it currently provides free and expanding non-insurance services. The paper also proposes lower caps for open-architecture distributors, which include brokers like Policybazaar, so the company's room to negotiate depends on how the final rules distinguish channels. Our read: the real lever is persuading the regulator to treat its model differently, not finding a new business line before the rules are final.

What makes brokers like Policybazaar cheaper to cap than insurers' own agents?

The regulator's new framework rests on a principle of 'same structure, same function, same norms.' Open-architecture distributors like Policybazaar, which can sell any insurer's products, get lower commission caps than closed-architecture distributors like tied agents. The rationale is that open-architecture sellers gain from multi-insurer placement and competitive efficiencies, so they need less incentive. An unintended consequence flagged is fewer options for policyholders, as low-premium motor policies become less attractive to sell. Our read: the caps deliberately reward insurers' captive sales forces over aggregators.

Could the volume growth from lower prices ever make up the lost commission?

PB Fintech's management argues yes, partly. With most general insurance partners, it operates on a combined operating ratio model, so if claims ratios or commissions decline, insurers can pass savings to customers through lower pricing. With a price elasticity of at least 1, the company expects 15-20% volume growth to partially offset revenue losses. But Bernstein still models FY28 profit falling below FY27 despite this offset, and its scenario assumes a 4% cut in premium growth anyway. Our read: volume offsets soften the blow, they do not reverse it.

What does the stock's roughly $4.5 billion value loss say about the market's confidence?

PB Fintech's market cap fell from about $9.07 billion in early September to $4.53 billion, a roughly 50% cut, even as quarterly profit rose 42.5% and revenue grew 35%. Brokerages remain split: Bernstein holds an 'Outperform' target, while HSBC and Dolat cut estimates, citing higher costs and regulatory uncertainty. The market is not doubting past results; it is pricing in a future where the core commission line shrinks. Our read: the market treats the current growth as partly purchased through spending that the new rules will force out, so investors want proof the model works under lower commissions.